✦ LIBER ✦

Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)

✍ Scribed by D. Galetta; V. Gebbia; S. Romito; F. Ferraù; F. De Marinis; S. Cigolari; S. Adamo; G. Colucci

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, fotemustine and whole-brain r

✍ Galetta, D.; Gebbia, V.; Silvestris, N.; Ferraù, F.; Carrozza, F.; Cigolari, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 446 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

9149 Phase II study of bevacizumab in co

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase II study with paclitaxel and gem

✍ Ginopoulos, P.; Danikas, D.D.; Asimakopoulos, C.; Mastronikolis, N.S.; Kiriazis, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Temozolomide in patients with advanced n

✍ R Dziadziuszko; A Ardizzoni; P.E Postmus; E.F Smit; A Price; C Debruyne; C Legra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Phase I/II and Pharmacokinetic Study of

✍ Pierre-Jean Souquet; Maciej Krzakowski; Rodrig Ramlau; Xu-Shan Sun; Guillermo Lo 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 484 KB